Veronica V Rezelj
7PUBLICATIONS
216CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 26, 2024
Safety and Humoral Immunogenicity of Different Dose Levels of Ad26.COV2.S as a 2-Dose Regimen in COVID-19 Vaccine-Naïve Healthy Adults: A Phase 3 Randomized Clinical Trial.Veronica V Rezelj, Fred Paddenburg, Marie Enajite Diegbe
|Jul 30, 2021
Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2.Tia A Tummino, Veronica V Rezelj, Benoit Fischer
|Apr 17, 2021
Defective viral genomes as therapeutic interfering particles against flavivirus infection in mammalian and mosquito hosts.Veronica V Rezelj, Lucía Carrau, Fernando Merwaiss
|Feb 08, 2021
Defective viral genomes from chikungunya virus are broad-spectrum antivirals and prevent virus dissemination in mosquitoes.Laura I Levi, Veronica V Rezelj, Annabelle Henrion-Lacritick
|Nov 06, 2020
An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike.Michael Schoof, Bryan Faust, Reuben A Saunders
|Oct 16, 2020
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.David E Gordon, Joseph Hiatt, Mehdi Bouhaddou
Pageof 2
Frequent Collaborators
5 joint publications
Marco Vignuzzi
4 joint publications
Thomas Vallet
3 joint publications
Laura I Levi
3 joint publications
Kris M White
3 joint publications
Nevan J Krogan
3 joint publications
Adolfo García-Sastre
2 joint publications
James Weger-Lucarelli
2 joint publications
Huong T Kratochvil
2 joint publications
Bryan Faust
2 joint publications
Christian Billesbølle
